Article
The CD8⁺T/MDSC ratio: A novel prognostic and predictive biomarker for immunotherapy response in gastric cancer
2026-04-14
Abstract excerpt
<title>Abstract</title> <p>Background Immune imbalance in tumor microenvironment is closely linked to GC progression. MDSCs primarily drive immune imbalance by suppressing the anti-tumor activity of CD8⁺T cells. Notably, no prior study has explored the combination of CD8⁺T cells and MDSCs to assess the clinical prognosis or immunotherapy response in GC. Methods PubMed and EMBASE were searched, literature screen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- edbabb46-2d11-5d5f-85e8-1b3a3c7fd01d
- DOI
- 10.21203/rs.3.rs-9286398/v1
